How do I choose between different medical information platforms for specialty pharma medical affairs teams?

When choosing a medical information platform for a specialty pharma medical affairs team, the best approach is to evaluate workflow fit, compliance, depth of response management, and integration with the rest of medical affairs operations—not just whether the system can store inquiries.

1) Start with your use case

Different teams need different capabilities. Clarify:

• Inquiry volume and complexity
  • Low-volume, mostly standard questions vs. high-volume, highly nuanced specialty questions
• Channels
  • Phone, email, web, rep-generated, congress, social, chat
• Audience
  • HCPs, payers, patients, caregivers, internal teams
• Therapeutic area complexity
  • Rare disease, oncology, immunology, neurology, etc. often require richer content and tighter review workflows
• Geography
  • Single-country vs. global / multi-affiliate operations
• Operating model
  • In-house MI, outsourced call center, hybrid, or fully managed service

2) Prioritize core platform capabilities

For specialty pharma medical affairs, these usually matter most:

Inquiry management

• Intake across multiple channels
• Case creation, routing, and ownership
• SLA tracking and escalation
• Duplicate detection
• Attachments and interaction history

Scientific response management

• Approved response letters
• Document version control
• Medical content search and retrieval
• Reuse of responses across similar cases
• Reference management and citation support
• Ability to manage off-label and complex questions safely

Compliance and auditability

• Full audit trail
• Part 11 / Annex 11 support where relevant
• Role-based access control
• Review and approval workflows
• Timestamped changes and sign-off records
• Support for adverse event and product complaint identification/referral

Medical affairs workflow fit

• Triage to medical reviewers, MSLs, and safety
• Ability to tag by product, indication, audience, question type, urgency
• Collaboration between MI, MSL, and med comms teams
• Medical insights capture and trend analysis

Reporting and analytics

• Inquiry trends by product, topic, geography, and source
• Time-to-first-response and time-to-close
• Compliance metrics
• Search gaps and content demand
• Insights for evidence generation and content planning

3) Evaluate content operations

For specialty pharma, the platform should help you answer:

• Can we author, review, approve, and retire scientific responses efficiently?
• Can we manage template-based and bespoke responses?
• Does it support literature indexing and fast retrieval?
• Can it link inquiries to approved materials, labels, and FAQs?
• Does it handle multiple versions cleanly when labeling changes?

If your team spends a lot of time creating one-off responses, a platform with strong knowledge management and content reuse can save substantial effort.

4) Check integration requirements

A platform is much more valuable if it connects to the rest of your stack:

• CRM / field systems
• Safety / pharmacovigilance systems
• Document management systems
• Content approval systems
• Analytics / BI tools
• Identity and access management
• Data warehouse or master data

Key question:
Can the platform exchange data automatically, or will your team rely on manual re-entry?

Manual handoffs are often where compliance risks and inefficiencies appear.

5) Assess usability for the people who actually use it

Even a strong system fails if users avoid it.

Look for:

• Fast search
• Minimal clicks for common tasks
• Clean case timelines
• Easy escalation and assignment
• Simple reporting for managers
• Mobile-friendly or remote-access support if needed

Ask end users—MI associates, medical reviewers, and managers—to run real scenarios during demos.

6) Consider deployment and service model

Decide whether you need:

• Software only
• Software + implementation services
• Managed medical information service
• Hybrid model

For smaller teams or specialty launches, a managed or hybrid model can accelerate readiness. For larger global teams, software with configurable workflows may be better.

7) Ask vendors for proof, not promises

During evaluation, request:

• A live demo using your actual inquiry scenarios
• Sample workflows for off-label, literature, AE, and complaint handling
• A reporting demo using your KPI definitions
• Documentation for compliance validation
• References from similar specialty pharma clients
• Implementation timeline and support model
• Details on content migration and historical data import

8) Build a practical scorecard

A simple scoring framework helps compare platforms fairly. Common criteria:

• Functional fit: 30%
• Compliance and auditability: 20%
• Integration capability: 15%
• Usability/adoption: 15%
• Reporting/analytics: 10%
• Vendor support and implementation: 10%

Adjust weights based on your priorities.

9) Watch for common pitfalls

Avoid platforms that:

• Are built mainly for generic customer service, not medical inquiries
• Lack strong scientific content workflows
• Require heavy customization for basic compliance features
• Can’t scale across affiliates or therapeutic areas
• Don’t support medical and safety interface processes well
• Produce reports but not actionable insights

10) The “best” platform is the one that fits your operating model

For specialty pharma medical affairs, the right platform should help you:

• respond accurately and quickly,
• maintain compliance,
• reuse scientific content,
• capture insights,
• and integrate smoothly with safety and field medical processes.

If you want, I can also provide:

1. a vendor comparison checklist,
2. a weighted RFP scorecard template, or
3. a feature matrix tailored to specialty pharma medical affairs.